Company News2015-12-25
Follow the trend of "manufacturing power", promote the "integration of industrialization and industrialization" of strong enterprises
The integration of industrialization and informationization. The 16th CPC national congress, 17th CPC national congress and 18th CPC national congress all proposed and promoted the development path of integration of the two systems. On May 8, 2015, the state council formally issued the first 10-year action program made in China 2025 for the implementation of the strategy of "manufacturing power" in China that made clear the strategic goal “ by 2025, the integration of industrialization and informatization will reach a new level.”
Company News2015-12-25
The company film 2015 annual field office will be held smoothly
This month, the studio office of the joint stock company industrial film will be successfully concluded, and the site office of the commercial film will be held next month. Company industrial film held a total of 10 on-site office meetings, the company's chairman Li Bbangliang led the company's leadership and related functional department leaders all attended.
Company News2015-11-28
Title of Honor
Huadong Health Child Shop received the title of “ Hangzhou five-star tourist goods outlets” and “ Hangzhou gift - tourism commodity standardization store”. Huadong Health Stadium Shop received the title of “ Hangzhou four-star tourist goods outlets”.
Company News2015-11-28
Major breakthroughs have been made in the localization of superantibiotics; Huadong Medicine research and development of dotomycin has been approved for listing
“ The success of doxycycline is a major weapon in our new drug development strategy.” The company head said, “ The new drug took seven years to fill the gap in China.”
Company News2015-11-16
Huadong Medicine started 2016 budget
On Sep.28, the company officially started the 2016 budget preparation according to the requirement of broad group, which is expected to continue until January.
Company News2015-11-01
Sino-US fourth quarter marketing work conference held smoothly
Sino-US 2015 fourth quarter marketing work conference was held During Oct.19 to 20.
Company News2015-11-01
Huadong Medicine awarded “ top 10 listed pharmaceutical and medical companies in China”
“ The 2015 China A-share listed company value ranking was released on Cct 16, 2015.” After being listed as "top 10 listed pharmaceutical and medical companies in the first China listed company value ranking list" last year, Huadong Medicine has been awarded the "top 10 listed pharmaceutical and medical companies in the second China listed company value ranking list" award this year.
Company News2015-09-28
Huadong Medicine awarded “ three prizes” at 2014 annual golden bull
Recently, China securities news unveiled the golden cow award for the 17th (2014) listed company, and east China pharmaceutical was the big winner, winning three awards, including 2014 top 100 listed companies of Jinniu, 2014 annual golden bull youth company and 2014 annual best company secretary.
Company News2015-09-28
The company speeds up personnel training and constantly improves internal training system
In order to further accelerate personnel training at all levels, promote the construction of the company's training system, so that talent development and staff training work can better support the realization of the company's strategy and business goals, the human resources department of the company started the "dandelion plan" at the beginning of this year, focusing on the training team for the establishment of the company.
Company News2015-09-25
The company has successfully passed the new GMP examination for several preparations and raw drug varieties
Recently, the company's capsules, tablets, granules, raw materials (the fermentation cordyceps sinensis powder) and raw materials (tacrolimus), and other products successfully passed the new GMP inspection.
Company News2015-09-25
Huadong Medicine listed top500 in Fortune China
Fortune China has released a list of the top 500 companies in China in 2015. Huadong Medicine Co.,Ltd., was again listed as the 268th place with solid growth operating performance, with 18.947 billion yuan of operating revenue.
Company News2015-07-25
Huadong Medicine 2015 corporate bonds were successfully issued and listed
On January 12 this year, the company received a reply from China securities regulatory commission, approving the company's public issuance of corporate bonds with face value not exceeding 1 billion yuan.
Our Company
